• Home
  • About Us
  • Products
  • Services
  • Partnerships
  • News

News

  • 2011
  • 2010
  • 2009
  • 2008
  • Upcoming Events

October 1, 2009

ImaginAb and BZL Biologics, LLC conclude licensing agreement for imaging rights to huJ591/Prostate-Specific Membrane Antigen

October 1, 2009

ImaginAb is awarded NCI SBIR contract in support of its work with huJ591/Prostate-Specific Membrane Antigen (PSMA)

September 24, 2009

ImaginAb announces “Imaximab” Line of Pre-Clinical Imaging Agents for use with PET and SPECT small animal imaging

September 23, 2009

ImaginAb exhibits its new line of targeted antibodies for preclinical imaging at the World Molecular Imaging Conference

September 17, 2009

ImaginAb, Inc. is invited to present at the 11th annual SoCalBio Investor and Partnership Conference

July 1, 2009

Dr. Dan Shochat, Ph.D joins the ImaginAb Scientific Advisory Board

March 4, 2009

ImaginAb co-founder Anna Wu gives a talk titled “Antibodies for molecular imaging of cancer” at the 3rd International Symposium on Antibody Engineering and Antibody-based Therapeutics in Taipei, Taiwan

February 23, 2009

ImaginAb to become a member of Southern California Biomedical Council (SoCalBio)